Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J02 ANTIMYCOTICS FOR SYSTEMIC USE
J02A ANTIMYCOTICS FOR SYSTEMIC USE
J02AC Triazole and tetrazole derivatives
J02AC04 Posaconazole
D02555 Posaconazole (JAN/USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Antifungals
Posaconazole
D02555 Posaconazole (JAN/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
61 Antibiotics
617 Acting mainly on mold
6179 Others
D02555 Posaconazole (JAN/USAN/INN)
Drug groups [BR:br08330]
Antifungal
DG01523 Triazole antifungal
D02555 Posaconazole
Metabolizing enzyme inhibitor
DG02852 CYP3A/CYP3A4 inhibitor
DG01522 CYP3A4 inhibitor
D02555 Posaconazole
Transporter substrate
DG01665 ABCB1 substrate
D02555 Posaconazole
Drug classes [BR:br08332]
Antifungal
DG01523 Triazole antifungal
D02555 Posaconazole
Antimicrobials [BR:br08307]
Antifungals
Ergosterol biosynthesis inhibitor
Triazole
D02555 Posaconazole (JAN/USAN/INN) <JP/US>
Antimicrobials abbreviations [BR:br08327]
Antifungals
Ergosterol biosynthesis inhibitor
Triazole
D02555 Posaconazole (JAN/USAN/INN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D02555
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D02555
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D02555
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D02555
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D02555
Drug transporters
D02555